Related Experiment Video

Updated: Oct 4, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of

C Kihara1, T Tsunoda, T Tanaka

  • 1Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan.

Cancer Research
|August 28, 2001
PubMed

Insights

This study introduces a gene expression method to predict esophageal cancer patient outcomes after chemotherapy. A novel scoring system based on 52 genes shows promise for personalized treatment prediction.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Adjuvant chemotherapy is standard for esophageal cancer post-surgery.
  • Predicting individual patient response to chemotherapy remains challenging.
  • Genetic markers could improve prognostic accuracy.

Purpose of the Study:

  • To develop a genetic method for predicting outcomes in esophageal cancer patients receiving adjuvant chemotherapy.
  • To identify specific genes correlated with patient survival and drug sensitivity/resistance.

Main Methods:

  • cDNA microarray analysis of 9216 genes in 20 esophageal cancer tissues.
  • Statistical analysis to identify genes associated with prognosis.
  • Development of a drug response score based on differential gene expression.

Main Results:

  • Identified 52 genes significantly correlated with patient prognosis.
  • Developed a drug response score demonstrating a significant correlation with patient outcomes.
  • The scoring system showed potential for predicting individual patient prognoses.

Conclusions:

  • A gene expression-based scoring system can predict esophageal cancer patient prognosis with adjuvant chemotherapy.
  • This method offers potential for personalized medicine in esophageal cancer treatment.
  • Further validation is warranted for clinical application.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...